Construction of shRNA targeting at ERK gene and its effect on expression of DcR3 protein in BGC823 cell line

FAN Xin,ZHUANG Guohong,HUANG Xiaoping,YANG Donghai,LIU Bin,LIU Zhongchen
DOI: https://doi.org/10.13431/j.cnki.immunol.j.20100249
2010-01-01
Abstract:To evaluate the molecular mechanism of gastric cancer,we constructed an ERK1/2 shRNA expression vector,and studied its effects on ERK1/2 protein and expression character of DcR3 in gastric cancer cell line BGC823 in vitro.We constructed ERK1/2 shRNA recombinant plasmid with PRNAT-U6.1/Neo vector,and then transfected the plasmid into BGC823 cells with liposome.Then three groups were assessed:blank control group,interference group,U0126 inhibitor group.Protein expressions of ERK1/2 in the three groups were detected by Western blot analysis;the expression of GFP was identified by Fluorescent microscope to observe the efficiency of transfection;the expression of DcR3 protein in BGC823 culture supernatant was examined by ELISA.We found that the expression levels of ERK1/2 protein were positively related with expression character of DcR3 in BGC823 cell line.All these results show that the protein expression levels of ERK1/2 are significantly down-regulated by ERK1/2 shRNA recombinant plasmid.Furthermore,ERK signaling pathway plays an important role in regulating expression levels of DcR3,which could promote the study of downstream regulating mechanism.
What problem does this paper attempt to address?